Alloimmunization and autoimmunization among multitransfused thalassemia and sickle cell disease patients
Blood transfusion is the mainstay for management of hemoglobinopathies, including thalassemia and sickle cell disease (SCD). Apart from other transfusion related adverse effects, immunization is a significant complication, particularly in multitransfused recipients. Alloimmunization rates vary widel...
Saved in:
Main Authors: | Sangeeta Pahuja (Author), Piali Mandal (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti Kp <sup>a</sup> antibody: A rare alloantibody in a multitransfused thalassemic of Indian origin
by: Pahuja Sangeeta, et al.
Published: (2010) -
Alloimmunization in children with sickle cell disease: A tertiary care experience
by: Sujata Sharma, et al.
Published: (2023) -
Red Blood Cell Alloimmunization in Pediatric group with Beta Thalassemia: A Five-Year Experience
by: Kiran Minhas MBBS FCPS, et al.
Published: (2022) -
Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease
by: Annamaria Aprile, et al.
Published: (2022) -
Prevalence of Sickle cell disease, Sickle cell trait and HBS-beta-thalassemia in India: A systematic review and Meta-analysis
by: Priyanka Rao, et al.
Published: (2024)